跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
乐可为 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Inclisiran Sodium Injection
Approved
化学药品
Inclisiran Sodium Injection
NOVARTIS EUROPHARM LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Aug 22, 2023
Approval ID
8TEMKoFQ8IS
Company
NOVARTIS EUROPHARM LIMITED
Type
化学药品
Approval Details
Approval Id
8TEMKoFQ8IS
Approval Number
国药准字HJ20230103
Generic Name
英克司兰钠注射液
Generic Name En
Inclisiran Sodium Injection
Trade Name
乐可为
Drug Type
化学药品
Dosage Form
注射剂
Strength
1.5ml:284mg(按英克司兰计)
Reg Date
2023-08-22
Expired Date
2028-08-21
Company Name
NOVARTIS EUROPHARM LIMITED
Production Company Name
Novartis Pharmaceutical Manufacturing GmbH
Company Detail Path
/organization/novartis-europharm-limited
Production Company Detail Path
/organization/novartis-pharmaceutical-manufacturing-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 22, 2023
Approval ID
8TEMKoFQ8IS
Type
化学药品
Back to NMPA Approvals